Bisnow

Organ Transplant Firm Leases 500K SF Somerville Tower For New HQ

Andover-based TransMedics Group signed a 498K SF lease for 188 Assembly Park Drive at BioMed Realty 's Assembly Innovation ...

Complex life on planets orbiting the galaxy's most common stars may be unlikely

In a blow to anyone dreaming that complex life may exist elsewhere in the universe, a new study suggests we're unlikely to ...

Solid Biosciences Inc.: Solid Biosciences Doses First Participant in First-in-Class Phase 1b FALCON Trial Evaluating SGT-212 Dual-Route Gene Therapy for the Treatment of ...

Solid Biosciences Inc. (Nasdaq: SLDB) (the "Company" or "Solid"), a life sciences company developing precision genetic medicines for neuromuscular ...

Ribo Life Enters Hong Kong Biotech Fast Lane After Strong Debut

Hong Kong investors can now trade in their first mRNA concept stock, following the strong trading debut for Suzhou Ribo Life ...
The Manila Times

Achieve Life Sciences Confirms Promotion of Dr. Mark Rubinstein to Chief Medical Officer

Since Dr. Rubinstein began his tenure as Interim CMO in September 2025, the company has achieved significant clinical and ...
pharmaphorum

Expanding the haematology toolkit: Insights and operational imperatives from ASH 2025

The 2025 American Society of Hematology (ASH) meeting in December presented a clear message: scientific innovation and ...
The Manila Times

Solid Biosciences Doses First Participant in First-in-Class Phase 1b FALCON Trial Evaluating SGT-212 Dual-Route Gene Therapy for the Treatment of Friedreich’s Ataxia

FALCON is a first-in-human, open-label, multi-center Phase 1b clinical trial designed to evaluate the safety and tolerability ...